Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Blueprint Medicines Corporation
Columbia University
Hospices Civils de Lyon
Istari Oncology, Inc.
Engeneic Pty Limited
Blueprint Medicines Corporation
Milton S. Hershey Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of California, San Francisco
Emory University
Eisai Inc.
Beijing Sanbo Brain Hospital
Henry Ford Health System
AbbVie
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Columbia University
Eli Lilly and Company
Cancer Research UK
Peking University Third Hospital
Grupo Español de Investigación en Neurooncología
Oncurious NV
Dana-Farber Cancer Institute
Emory University
Angiochem Inc
Celldex Therapeutics
National Institutes of Health Clinical Center (CC)
The Hospital for Sick Children
Children's Mercy Hospital Kansas City
University of California, San Francisco
Universitair Ziekenhuis Brussel
University of California, San Francisco
University Hospital, Bonn
Children's Mercy Hospital Kansas City
University of Michigan
Clinica Universidad de Navarra, Universidad de Navarra
Children's Oncology Group
Novartis
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
University of Louisville
University of Louisville
Fred Hutchinson Cancer Center
Assistance Publique - Hôpitaux de Paris
Children's Oncology Group
Duke University
Novartis
Duke University